创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

CHEN Huan, WEI Lijun. Advances in Research on Non-viral Delivery Systems for RNA Drugs[J]. Progress in Pharmaceutical Sciences, 2022, 46(11): 839-847. DOI: 10.20053/j.issn1001-5094.2022.11.005
Citation: CHEN Huan, WEI Lijun. Advances in Research on Non-viral Delivery Systems for RNA Drugs[J]. Progress in Pharmaceutical Sciences, 2022, 46(11): 839-847. DOI: 10.20053/j.issn1001-5094.2022.11.005

Advances in Research on Non-viral Delivery Systems for RNA Drugs

  • RNA therapy, which regulates gene expression by introducing exogenous RNAs into specific cells, is a very promising strategy for disease treatment. However, the delivery of RNA drugs require suitable drug delivery systems, because RNAs are unstable in vivo and cannot enter target cells efficiently. Compared with viral vectors, non-viral vectors are safer, and have become a research hotspot. In this article, we mainly introduced three non-viral delivery systems that may enable the clinical translation of RNA therapeutics:lipid nanoparticle delivery systems, bioconjugation delivery systems, and exosome delivery systems. The related technical progress and difficulties were also analyzed and summarized.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return